Sloppy’ Michael Moore Broadway Show a ‘Total
Sloppy’ Michael Moore Broadway Show a ‘Total Bomb’
what you can't call him a fat slob ?? < >
President Donald Trump took on one his most vocal celebrity critics Saturday in a message posted to his Twitter account, calling filmmaker Michael Moore’s anti-Trump summer Broadway show a “total bomb” that was “forced to close.”
“While not at all presidential I must point out that the Sloppy Michael Moore Show on Broadway was a TOTAL BOMB and was forced to close. Sad!” Trump tweeted Saturday evening about Moore’s show.
Trump was, of course, referring to Moore’s Broadway show The Terms of My Surrender, a play in which the filmmaker took aim at Trump and his policies and often brought out celebrity guests to help bash the president. The play opened in late summer and ran for twelve weeks at New York City’s Belasco Theater.
According to industry box office tracking at BroadwayWorld.com, Moore’s show grossed a total of $4.2 million during its run, or less than half of what it had the potential to make. Through its final seven weeks, the show managed to gross over 40 percent of its potential earnings just once, according to the site.
The show was also mostly panned by critics, with one Los Angeles Times reviewer calling it a “support group for disheartened Democrats,” and one in which Moore casts himself both as a “victim of the right” and a “champion of all mankind.”
Moore fired back at the president Saturday in a series of tweets, explaining that the show had always been intended to play as a limited engagement and saying at least one senior member of Trump’s White House was a fan of the filmmaker’s.
“You must have my smash hit of a Broadway show confused with your presidency- which IS a total bomb and WILL indeed close early. NOT SAD,” Moore wrote in the first of eleven messages.
Moore also suggested that Trump was using the play as his “latest distraction” from his “crimes,” and called the president a “loser.”
“For now, at least, I know I still have one fan in the White House (thx for your unwavering support Jared!)” he concluded his tweets.
In originally announcing the show, the documentary filmmaker said he wanted to see if a piece of theater “could raise enough of a ruckus to discombobulate a man sitting in the Oval Office.”
During one August performance, Moore took the audience that had come to see him that night on a pair of double-decker buses to a protest outside Trump Tower, where he was joined by celebrities including Mark Ruffalo and Olivia Wilde.
Moore told the audience at the protest that the group was there to perform a “citizen’s arrest.”
The filmmaker’s Broadway show closed this week. He has since announced his desire to take the show on tour across the country.
Now that is another face
Is that a wierd guy or what.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Top 5 Most Recently Viewed Articles
Pathlabs Hires JC Clarke to Spearhead Agency Growth Pathlabs, a leading name in the digital media execution space, is thrilled to announce the appointment of JC Clarke as Vice President of Agency Growth. This strategic addition comes as the company continues to innovate and enhance its services for independent agencies. JC Clarke's Impressive Background Clarke brings with...
Continue Reading
Understanding the Class Action Against Constellation Brands, Inc. Many investors are currently seeking information about the class action lawsuit involving Constellation Brands, Inc. (NASDAQ: STZ). Robbins LLP has brought this to light by urging shareholders to be aware of their rights following this significant event. The class action involves all investors who bought...
Continue Reading
Robert Griffin Retires as Chairman of the Board Commercial Vehicle Group, Inc., often referred to as CVG, has announced a notable transition within its Board of Directors. Robert C. Griffin, who has been a pillar of leadership since 2005, will retire effective May 15, 2025. His decision not to seek re-election during the upcoming stockholders' meeting marks the end of an...
Continue Reading
Investment Highlights from Major Companies In a recent installment of CNBC's final trades, Richard Saperstein, managing director and chief investment officer of Treasury Partners, identified Vistra Corp. (NYSE: VST) as a noteworthy investment choice. His enthusiasm follows a significant endorsement from Wells Fargo analyst Shahriar Pourreza, who initiated coverage with an...
Continue Reading
Evercore ISI's Analysis of Verisk Analytics Recently, Evercore ISI began its coverage of Verisk Analytics (NASDAQ: VRSK), a prominent data analytics provider. They assigned an In Line rating to the stock, setting a new price target of $279. The firm acknowledged the robust financial performance of Verisk, particularly emphasizing its high profit margins, which hover...
Continue Reading